Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/308% below fair value
$3.19−0.08 (-2.45%)
Close on Nov 17, 2026Market cap $1.18BP/E 16.0Yield –
Cronos price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cronos's price to book ratio was 1.2× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.6× to 1.2×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | +0.3 |
| 2025 | Dec 31, 2025 | 0.9× | +0.2 |
| 2024 | Dec 31, 2024 | 0.7× | +0.0 |
| 2023 | Dec 29, 2023 | 0.7× | −0.1 |
| 2022 | Dec 30, 2022 | 0.8× | −0.2 |
| 2021 | Dec 31, 2021 | 1.0× | −0.4 |
| 2020 | Dec 31, 2020 | 1.4× | – |
See a number that looks wrong?